Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-27

Clinical Trial Update: Fluids in Septic Shock (FISSH) [Phase 2, Phase 3]

View source ↗

Summary

The Fluids in Septic Shock (FISSH) trial, spanning Phase 2 and Phase 3, has completed its studies. It investigates fluid therapy options for sepsis and septic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McMaster University | Conditions: Sepsis, Septic Shock | Phase 2, Phase 3 | Status: COMPLETED